The healthcare landscape for diabetes is evolving, and these patches represent a exciting development. Unlike shots, this approach offers a more convenient way to administer GLP-1 therapies. These devices steadily release the treatment through the epidermis offering a stable level of the therapeutic agent, which can improve blood sugar regulation a